ClinicalTrials.Veeva

Menu

Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis (MEASURE-cBP2)

U

Universitätsmedizin Mannheim

Status

Completed

Conditions

Healthy Control
Coronary Heart Disease
Diabetes Mellitus
Arterial Hypertension

Study type

Observational

Funder types

Other

Identifiers

NCT03049709
VA_noninvasive

Details and patient eligibility

About

There is growing evidence that central blood pressure is a better predictor of hypertensive end-organ damage and cardiovascular outcome than routine brachial readings.

The investigators aimed to evaluate the accuracy of a novel device for the non-invasive determination of central blood pressure based on automated oscillometric radial pulse wave analysis.

Enrollment

119 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cardiovascular disease, diabetes mellitus or healthy control

Exclusion criteria

  • inability to give informed consent
  • hemodynamic instability

Trial design

119 participants in 2 patient groups

cardiovascular disease
Description:
patients with cardiovascular disease, invasive and non-invasive determination of central blood pressure
healthy controls
Description:
healthy controls, invasive and non-invasive determination of central blood pressure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems